Jun 212018
 

By operator Feed Up

Talent4Boards - Great Talent builds Great Boards

– UK, London – Silence Therapeutics plc (AIM:SLN), a leader in the discovery, delivery and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces today the appointment of Dave Lemus to its Board as Non-Executive Director effective immediately.… => Read full post

Silence Therapeutics appoints Dave Lemus to its Board as Non-Executive Director

From:: Silence Therapeutics appoints Dave Lemus to its Board as Non-Executive Director

Sorry, the comment form is closed at this time.

%d bloggers like this: